February 2016

The latest from Cogstate, leaders in optimizing the measurement of cognition

Cogstate Welcomes Jessica Gordon, M.A., Scales & Rater Training Director

February 29, 2016

Jessica oversees the Scales & Rater Training department at Cogstate, leading a growing and diverse team of experts, continuously refining systems and processes to optimize delivery of rater training solutions. Prior to joining Cogstate, Jessica was co-founder of ProPhase, LLC, a specialty service provider for applied measurement solutions in CNS therapeutic areas. There she managed […]

Heart Health And Cognitive Function Linked In New Study

February 23, 2016

While today’s medical research tends to divide the human body into separate systems to better focus on specific disease states, our overall health is still an integrated whole. Two of these systems, cardiovascular and the central nervous system, have been shown to influence each other. A heart suffering from cardiovascular disease can affect the available […]

Combined Antiretroviral Therapy With Maraviroc Improves HIV-associated Neurocognitive Dysfunction

February 17, 2016

Many people with HIV infection report that they have problems in thinking clearly and accurately. Formal neuropsychological studies using objective assessment techniques show that, at all stages of HIV severity, people can have difficulty with attention, memory, language, problem solving and decision making. Known as HIV-associated neurocognitive disorders (HAND), symptoms can include confusion, forgetfulness, headaches, […]

FDA Advisory Committee Support of Brintellix for Cognitive Dysfunction in Depression: A Re-consideration of What Makes a Clinically Meaningful Cognitive Deficit

February 12, 2016

Takeda and Lundbeck announced recently that the U.S. FDA Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD). There has been a great deal of optimism and analysis about what […]

Predicting Surgery-Related Cognitive Dysfunction Using An Alzheimer’s Disease Biomarker

February 9, 2016

With average lifespans increasing thanks to improved medical care and healthy habits, older adults are undergoing more major surgeries, whether it be for cardiac care or orthopaedic conditions. However, one of the side effects of operations requiring significant anesthesia is a form of cognitive decline immediately after recovery that may last for weeks or months. […]